The estimated Net Worth of Michael Mc Dermott is at least $2.83 Million dollars as of 23 February 2024. Michael Dermott owns over 12,412 units of Pfizer stock worth over $2,829,801 and over the last 3 years Michael sold PFE stock worth over $0.
Michael has made over 5 trades of the Pfizer stock since 2022, according to the Form 4 filled with the SEC. Most recently Michael exercised 12,412 units of PFE stock worth $339,344 on 23 February 2024.
The largest trade Michael's ever made was exercising 14,952 units of Pfizer stock on 23 February 2022 worth over $408,788. On average, Michael trades about 11,198 units every 122 days since 2022. As of 23 February 2024 Michael still owns at least 95,408 units of Pfizer stock.
You can see the complete history of Michael Dermott stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read und James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: